Maharashtra FDA Launches Statewide Crackdown On Ayurvedic Drug Makers, Cancels 10 Licences Over Serious GMP & Quality Violations
Mumbai: The Maharashtra Food and Drug Administration (FDA) has launched a statewide crackdown on Ayurvedic drug manufacturers after inspections found serious violations of prescribed manufacturing and quality-control standards at several establishments. Maharashtra FDA inspected 434 Ayurvedic drug manufacturers statewide and issued 135 show-cause notices for violations. Licences of 10 firms were…
Maharashtra Food and Drug Administration (FDA) has intensified its scrutiny of Ayurvedic drug manufacturers, announcing a statewide crackdown following serious violations of manufacturing and quality-control standards. Inspecting 434 Ayurvedic drug producers across the state, the FDA issued 135 show-cause notices and permanently cancelled the licences of 10 firms due to critical quality and safety lapses.
The FDA warned manufacturers to adhere strictly to Good Manufacturing Practices (GMP) or face stringent consequences, stressing the importance of meeting prescribed standards to ensure medicine quality, safety and efficacy.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
